AIDS News and Research

RSS

How innovative technology aids in the fight against diabetes epidemic

Dr Chris Tackaberry, CEO of healthtech AI pioneers Clinithink, highlights the crisis facing the NHS and the importance of Diabetes Week from June 12-18. Every week, diabetes leads to around 180 amputations, 590 heart attacks and 2,300 cases of heart failure. The financial impact of this on the NHS is eye watering.

10 Jun 2023

Study shows how blood makes the brain’s immune cells toxic

In patients with neurological diseases like Alzheimer's disease and multiple sclerosis, immune cells in the brain known as microglia that normally fulfill beneficial functions become harmful to neurons, leading to cognitive dysfunction and motor impairment.

8 Jun 2023

Experts provide neural evidence for the glimpsing model of speech perception

Researchers led by Dr. Nima Mesgarani at Columbia University, US, report that the brain treats speech in a crowded room differently depending on how easy it is to hear, and whether we are focusing on it. Publishing June 6th in the open access journal PLOS Biology, the study uses a combination of neural recordings and computer modeling to show that when we follow speech that is being drowned out by louder voices, phonetic information is encoded differently than in the opposite situation. The findings could help improve hearing aids that work by isolating attended speech.

7 Jun 2023

Uganda’s anti-homosexuality legislation sparks global condemnation

Uganda's anti-homosexuality legislation, which includes the death penalty for offenders, was signed into law on Monday by President Yoweri Museveni, sparking international condemnation.

6 Jun 2023

California confronts the threat of ‘tranq’ as overdose crisis rages

When the city's medical examiner announced in February that four people who had recently died of overdoses had the animal sedative xylazine in their systems, public health workers across the state sprang into action.

5 Jun 2023

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly lower risk of their cancer getting worse than patients treated with brentuximab vedotin, a monoclonal antibody, and AVD (BV-AVD) a year after starting treatment.

4 Jun 2023

Study shows humans may have evolved a spring-like arch to help us walk on two feet

A recent study hypothesized that the arch recoils to propel the COM, which affects the ankle posture.

2 Jun 2023

New method may help identify the essential ingredients for making an effective HIV vaccine

Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, according to the World Health Organization (WHO).

30 May 2023

Virally mediated gene therapy could potentially treat genetic hearing loss

By 2050, one in 10 individuals are expected to live with some form of hearing loss. Of the hundreds of millions of cases of hearing loss affecting individuals worldwide, genetic hearing loss is often the most difficult to treat.

26 May 2023

Study highlights two strategies used by Salmonella to escape the human body's defenses

Like thieves that constantly look for ways to evade capture, Salmonella enterica, a disease-causing bacterium, uses various tactics to escape the human body's defence mechanisms.

26 May 2023

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

New animal research is helping explain why at least five people have become HIV-free after receiving a stem cell transplant.

25 May 2023

Placebo effect in technical applications increases risk-taking behavior

Human augmentation technologies refer to technological aids that enhance human abilities. They include things like exoskeletons, but also augmented reality headsets.

25 May 2023

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the IAVI G001 Phase 1 clinical trial to test the safety and immune response of a self-assembling nanoparticle HIV vaccine.

25 May 2023

AIDS News and Research

How innovative technology aids in the fight against diabetes epidemic

Study shows how blood makes the brain’s immune cells toxic

Experts provide neural evidence for the glimpsing model of speech perception

Uganda’s anti-homosexuality legislation sparks global condemnation

California confronts the threat of ‘tranq’ as overdose crisis rages

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

Study shows humans may have evolved a spring-like arch to help us walk on two feet

New method may help identify the essential ingredients for making an effective HIV vaccine

Virally mediated gene therapy could potentially treat genetic hearing loss

Study highlights two strategies used by Salmonella to escape the human body's defenses

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

Placebo effect in technical applications increases risk-taking behavior

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Assessing multimodal IFG abnormalities in individuals with a familial risk for BD

Scientists study the structure and function of a transporter involved in cancer, immunity

Processed danger: Industrial food additives and the health risks to children

Researchers use machine learning to identify "synthetic extreme" DNA sequences

Novel gene-editing strategy harnesses an unusual protective ability to eliminate HIV-1 infection

Study claims that mask-wearing is still as necessary in healthcare settings

New process for automated and highly accurate reporting of NGS-based clonality testing

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News